150 related articles for article (PubMed ID: 18951772)
1. Linoleic acid and coronary heart disease.
Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):169-71. PubMed ID: 18951772
[TBL] [Abstract][Full Text] [Related]
2. Health effects of trans-fatty acids: experimental and observational evidence.
Mozaffarian D; Aro A; Willett WC
Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.
Huxley R; Lewington S; Clarke R
Semin Vasc Med; 2002 Aug; 2(3):315-23. PubMed ID: 16222621
[TBL] [Abstract][Full Text] [Related]
4. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease.
Willett WC
J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S42-5. PubMed ID: 17876199
[TBL] [Abstract][Full Text] [Related]
5. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
[TBL] [Abstract][Full Text] [Related]
6. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence.
Mozaffarian D
Altern Ther Health Med; 2005; 11(3):24-30; quiz 31, 79. PubMed ID: 15945135
[TBL] [Abstract][Full Text] [Related]
7. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies.
Farvid MS; Ding M; Pan A; Sun Q; Chiuve SE; Steffen LM; Willett WC; Hu FB
Circulation; 2014 Oct; 130(18):1568-78. PubMed ID: 25161045
[TBL] [Abstract][Full Text] [Related]
8. Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult men.
Angela Liou Y; Innis SM
Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):201-6. PubMed ID: 19356914
[TBL] [Abstract][Full Text] [Related]
9. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components.
Ghafoorunissa
Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of saturated fat and cholesterol intakes on serum lipids: Tehran Lipid and Glucose Study.
Mirmiran P; Ramezankhani A; Azizi F
Nutrition; 2009 May; 25(5):526-31. PubMed ID: 19121920
[TBL] [Abstract][Full Text] [Related]
11. An examination of the evidence supporting the association of dietary cholesterol and saturated fats with serum cholesterol and development of coronary heart disease.
Volk MG
Altern Med Rev; 2007 Sep; 12(3):228-45. PubMed ID: 18072819
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor re: Linoleic acid and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids (2008), by W.S. Harris.
Ramsden CE; Hibbeln JR; Lands WE
Prostaglandins Leukot Essent Fatty Acids; 2009 Jan; 80(1):77; author reply 77-8. PubMed ID: 19147338
[No Abstract] [Full Text] [Related]
13. Cholesterol and coronary events. The current thinking.
Jones PH
Postgrad Med; 2003 Apr; 113(4 Suppl):5-14. PubMed ID: 19667618
[TBL] [Abstract][Full Text] [Related]
14. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
15. The health implications of changing linoleic acid intakes.
Whelan J
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):165-7. PubMed ID: 18990554
[TBL] [Abstract][Full Text] [Related]
16. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men.
Poudel-Tandukar K; Nanri A; Matsushita Y; Sasaki S; Ohta M; Sato M; Mizoue T
Nutr Res; 2009 Jun; 29(6):363-70. PubMed ID: 19628101
[TBL] [Abstract][Full Text] [Related]
17. The American Heart Association advisory on n-6 fatty acids: evidence based or biased evidence?
Calder PC
Br J Nutr; 2010 Dec; 104(11):1575-6. PubMed ID: 21118616
[No Abstract] [Full Text] [Related]
18. The patient at risk: who should we be treating?
Leitersdorf E
Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
[TBL] [Abstract][Full Text] [Related]
19. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.
de Rojas FD; De Frutos T; Ponte A; Chacón JM; Vitale GC;
Prev Cardiol; 2009; 12(2):65-71. PubMed ID: 19476579
[TBL] [Abstract][Full Text] [Related]
20. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
